BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim JW, Atkins C, Wilson AM. Barriers to specialist palliative care in interstitial lung disease: a systematic review. BMJ Support Palliat Care 2019;9:130-8. [DOI: 10.1136/bmjspcare-2018-001575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Rodrigo-Troyano A, Alonso A, Barril S, Fariñas O, Güell E, Pascual A, Castillo D. Impact of Early Referral to Palliative Care in Patients with Interstitial Lung Disease. J Palliat Med 2022. [PMID: 35714348 DOI: 10.1089/jpm.2021.0458] [Reference Citation Analysis]
2 Chai GT, Neo HY, Abisheganaden J, Hum AYM. Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients. Am J Hosp Palliat Care 2022;:10499091221083575. [PMID: 35389277 DOI: 10.1177/10499091221083575] [Reference Citation Analysis]
3 Lüthi FT, Bernard M, Gamondi C, Ramelet AS, Borasio GD. ID-PALL: An Instrument to Help You Identify Patients in Need of Palliative Care. Praxis (Bern 1994) 2021;110:839-44. [PMID: 34814722 DOI: 10.1024/1661-8157/a003788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Johannson KA, Chaudhuri N, Adegunsoye A, Wolters PJ. Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet 2021;398:1450-60. [PMID: 34499866 DOI: 10.1016/S0140-6736(21)01826-2] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cassidy N, Fox L, Love M, Byrne I, Doyle AM, Korn B, Shanagher D, Shone T, Cullen M, Cullen T, Mullaney P, O'Carroll N, O'Dowd G, O'Sullivan T, Russell AM. Fibrotic interstitial lung disease - palliative care needs: a World-Café qualitative study. BMJ Support Palliat Care 2021:bmjspcare-2021-003249. [PMID: 34635541 DOI: 10.1136/bmjspcare-2021-003249] [Reference Citation Analysis]
6 Chaaban S, McCormick J, Gleason D, McFarlin JM. Palliative Care for the Interstitial Lung Disease Patient a Must and Not Just a Need. Am J Hosp Palliat Care 2021;:10499091211040232. [PMID: 34409885 DOI: 10.1177/10499091211040232] [Reference Citation Analysis]
7 Liu QW, Qin T, Hu B, Zhao YL, Zhu XL. Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: A cross-sectional study. J Clin Nurs 2021. [PMID: 33998090 DOI: 10.1111/jocn.15852] [Reference Citation Analysis]
8 Teike Lüthi F, Bernard M, Vanderlinden K, Ballabeni P, Gamondi C, Ramelet AS, Borasio GD. Measurement Properties of ID-PALL, A New Instrument for the Identification of Patients With General and Specialized Palliative Care Needs. J Pain Symptom Manage 2021;62:e75-84. [PMID: 33781917 DOI: 10.1016/j.jpainsymman.2021.03.010] [Reference Citation Analysis]
9 Kim JW, Olive S, Jones S, Thillai M, Russell AM, Johnson MJ, Wilson A. Interstitial lung disease and specialist palliative care access: a healthcare professionals survey. BMJ Support Palliat Care 2020:bmjspcare-2019-002148. [PMID: 32561550 DOI: 10.1136/bmjspcare-2019-002148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]